US Patent 11136317 NADPH oxidase 4 inhibitors
Patent 11136317 was granted and assigned to Actelion on October, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+114 characters)
Article
Patent abstract
The invention relates to 2,5-disubstituted benzoxazole and benzothiazole derivatives of Formula (I)
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Christoph Boss0
Hamed Aissaoui0
Martin Bolli0
Patrick Sieber0
Sylvia Richard-Bildstein0
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Oct, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11136317 NADPH oxidase 4 inhibitors
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11136317
Date of patent
October 5, 2021
Patent application number
20200130
Date Filed
January 30, 2020
Find more entities like US Patent 11136317 NADPH oxidase 4 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
